Compare MIST & SRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MIST | SRBK |
|---|---|---|
| Founded | 2003 | 1887 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.3M | 140.5M |
| IPO Year | 2019 | 2023 |
| Metric | MIST | SRBK |
|---|---|---|
| Price | $1.32 | $19.86 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 40.7K |
| Earning Date | 05-13-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.04% |
| EPS Growth | N/A | ★ 138.36 |
| EPS | N/A | ★ 0.31 |
| Revenue | N/A | N/A |
| Revenue This Year | $2,915.14 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $63.32 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $13.47 |
| 52 Week High | $3.06 | $20.20 |
| Indicator | MIST | SRBK |
|---|---|---|
| Relative Strength Index (RSI) | 45.54 | 62.21 |
| Support Level | $1.20 | $18.51 |
| Resistance Level | $1.42 | N/A |
| Average True Range (ATR) | 0.07 | 0.43 |
| MACD | 0.02 | 0.06 |
| Stochastic Oscillator | 54.55 | 63.43 |
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.